GLUE - CIK 0001826457
Monte Rosa Therapeutics, Inc. trades as GLUE and has a market capitalization of $1.39 B, making it the #2397 largest US-listed company by market value. This page tracks Monte Rosa Therapeutics, Inc. through 352 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-21 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
The largest companies sharing Monte Rosa Therapeutics, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).
Monte Rosa Therapeutics, Inc. (GLUE) has a market capitalization of $1.39 B as of 2026-06-10, ranking #2397 among US-listed companies.
In its latest fiscal year Monte Rosa Therapeutics, Inc. reported a net loss of $38.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.